Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins

The COVID-19 pandemic highlighted the urgent need for life-saving treatments, including vaccines, drugs, and therapeutic antibodies, delivered at unprecedented speed. During this period, recombinant antibody research and development cycle times were substantially shortened without compromising quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Broly, Hervé, Souquet, Jonathan, Beck, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246481/
https://www.ncbi.nlm.nih.gov/pubmed/37278452
http://dx.doi.org/10.1080/19420862.2023.2220150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246481/
https://www.ncbi.nlm.nih.gov/pubmed/37278452
http://dx.doi.org/10.1080/19420862.2023.2220150

Ejemplares similares